A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
This study will evaluate four different modified release formulation to estimate the amount of dimebon available to the body relative to the current dimebon formulation that is given three times a day. The results of this study will help inform and guide further formulation development efforts with the ultimate goal of reducing dose frequency to once-a-day or twice-a-day.
Epistemonikos ID: 4ef6e82e161edb0b0c1df24c566c6a8f3a8411f1
First added on: Mar 30, 2022